Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study

被引:69
作者
de la Fuente-Sandoval, Camilo [1 ,2 ]
Leon-Ortiz, Pablo [1 ]
Azcarraga, Mariana [1 ]
Favila, Rafael [3 ]
Stephano, Sylvana [2 ]
Graff-Guerrero, Ariel [4 ,5 ,6 ]
机构
[1] Inst Nacl Neurol & Neurocirug, Expt Psychiat Lab, Mexico City, DF, Mexico
[2] Inst Nacl Neurol & Neurocirug, Neuropsychiat Dept, Mexico City, DF, Mexico
[3] GE Healthcare, MR Adv Applicat, Mexico City, DF, Mexico
[4] Univ Toronto, Multimodal Neuroimaging Schizophrenia Grp, Res Imaging Ctr, Schizophrenia Program, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Geriatr Mental Hlth Program, Ctr Addict & Mental Hlth, Toronto, ON M5S 1A1, Canada
[6] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada
关键词
Associative-striatum; glutamate; H-1-MRS; prodromal; psychosis; PRODROMAL SYMPTOMS; EPISODE PSYCHOSIS; DOPAMINE RELEASE; SCHIZOPHRENIA; PREDICTION; HYPOTHESIS;
D O I
10.1017/S1461145712000314
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Increased glutamate levels in the associative-striatum have been described in subjects at ultra-high risk for psychosis (UHR); nevertheless, it is unclear whether this abnormality predicts the conversion to psychosis. Nineteen subjects at UHR and 26 controls were studied using proton magnetic resonance spectroscopy. Subjects at UHR were clinically followed for 2 yr. Seven UHR subjects (37%) transitioned to a psychotic disorder and the remaining 12 did not exhibit psychotic symptoms at the most recent follow-up. The psychosis transition group had higher glutamate levels compared to both non-transition and control groups (p=0.02 and p<0.01, respectively; effect size 1.39). These pilot findings suggest that the conversion to psychosis is associated with increased glutamate levels in the associative-striatum.
引用
收藏
页码:471 / 475
页数:5
相关论文
共 23 条
[1]
Breier A, 1998, SYNAPSE, V29, P142, DOI 10.1002/(SICI)1098-2396(199806)29:2<142::AID-SYN5>3.0.CO
[2]
2-7
[3]
Prediction of psychosis in youth at high clinical risk [J].
Cannon, Tyrone D. ;
Cadenhead, Kristin ;
Cornblatt, Barbara ;
Woods, Scott W. ;
Addington, Jean ;
Walker, Elaine ;
Seidman, Larry J. ;
Perkins, Diana ;
Tsuang, Ming ;
McGlashan, Thomas ;
Heinssen, Robert .
ARCHIVES OF GENERAL PSYCHIATRY, 2008, 65 (01) :28-37
[4]
INTERACTIONS BETWEEN GLUTAMATERGIC AND MONOAMINERGIC SYSTEMS WITHIN THE BASAL GANGLIA - IMPLICATIONS FOR SCHIZOPHRENIA AND PARKINSONS-DISEASE [J].
CARLSSON, M ;
CARLSSON, A .
TRENDS IN NEUROSCIENCES, 1990, 13 (07) :272-276
[5]
Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis [J].
de la Fuente-Sandoval, Camilo ;
Leon-Ortiz, Pablo ;
Favila, Rafael ;
Stephano, Sylvana ;
Mamo, David ;
Ramirez-Bermudez, Jesus ;
Graff-Guerrero, Ariel .
NEUROPSYCHOPHARMACOLOGY, 2011, 36 (09) :1781-1791
[6]
First MB., 1997, STRUCTURED CLIN INTE
[7]
Gating of information flow within the limbic system and the pathophysiology of schizophrenia [J].
Grace, AA .
BRAIN RESEARCH REVIEWS, 2000, 31 (2-3) :330-341
[8]
Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study [J].
Howes, Oliver D. ;
Bose, Subrata K. ;
Turkheimer, Federico ;
Valli, Isabel ;
Egerton, Alice ;
Valmaggia, Lucia R. ;
Murray, Robin M. ;
McGuire, Philip .
AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (12) :1311-1317
[9]
The Dopamine Hypothesis of Schizophrenia: Version III - The Final Common Pathway [J].
Howes, Oliver D. ;
Kapur, Shitij .
SCHIZOPHRENIA BULLETIN, 2009, 35 (03) :549-562
[10]
JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301